Global
The company with the highest Price to Sales Ratio (P/S) is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at 208,296,864.00.
The company with the lowest Price to Sales Ratio (P/S) is Tennessee Valley Authority PARRS D 2028 (NYSE: TVC) at 0.00.
The top 10 companies the Global by Price to Sales Ratio (P/S) are Inhibikase Therapeutics, Inc., Molecure S.A., De Grey Mining Limited, Genomtec S.A., Gatos Silver, Inc., Deep Yellow Limited, LQwD FinTech Corp., BrightPath Biotherapeutics Co., Ltd., NanoGroup S.A. and Benitec Biopharma Inc..
The bottom 10 companies by Price to Sales Ratio (P/S) are Tennessee Valley Authority PARRS D 2028, Air Industries Group, Snail, Inc. Class A Common Stock, Streamline Health Solutions, Inc., Compuage Infocom Limited, Ispire Technology Inc., Grupo Casas Bahia S.A., C-Lab Ltd, Mobility One Ltd. and PT Asia Pacific Fibers Tbk.